Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis.

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Future Science OA Pub Date : 2024-12-31 Epub Date: 2024-08-25 DOI:10.1080/20565623.2024.2365125
Syed Hamza Haider, Areeka Irfan, Samir Mustafa Sheikh, Muhammad Taha Abid, Turba Naz, Mudassir Abbas, Alishba Raza
{"title":"Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis.","authors":"Syed Hamza Haider, Areeka Irfan, Samir Mustafa Sheikh, Muhammad Taha Abid, Turba Naz, Mudassir Abbas, Alishba Raza","doi":"10.1080/20565623.2024.2365125","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This meta-analysis investigates the association between testosterone replacement therapy [TRT] and carotid artery atherosclerosis. <b>Methods:</b> 3 databases were searched for studies up to June 2023 per the PRISMA guidelines. The eligibility criteria comprised RCTs and observational studies involving hypogonadal males receiving exogenous testosterone, in which CIMT was assessed. CAA was the primary outcome, whereas secondary outcomes included HDL, LDL, CRP, total cholesterol and total testosterone. The statistical analysis was performed using Review Manager. <b>Results:</b> Statistical analysis revealed no association between TRT and assessed outcomes. There was a significant increase in total testosterone levels, depicting indirect anti-atherosclerotic effects of TRT. <b>Conclusion:</b> Meta-analysis shows no relation between TRT and CIMT or other markers, allowing its safe usage for hypogonadal males.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11352792/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20565623.2024.2365125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This meta-analysis investigates the association between testosterone replacement therapy [TRT] and carotid artery atherosclerosis. Methods: 3 databases were searched for studies up to June 2023 per the PRISMA guidelines. The eligibility criteria comprised RCTs and observational studies involving hypogonadal males receiving exogenous testosterone, in which CIMT was assessed. CAA was the primary outcome, whereas secondary outcomes included HDL, LDL, CRP, total cholesterol and total testosterone. The statistical analysis was performed using Review Manager. Results: Statistical analysis revealed no association between TRT and assessed outcomes. There was a significant increase in total testosterone levels, depicting indirect anti-atherosclerotic effects of TRT. Conclusion: Meta-analysis shows no relation between TRT and CIMT or other markers, allowing its safe usage for hypogonadal males.

评估睾酮替代疗法对颈动脉粥样硬化的影响:系统回顾和荟萃分析。
目的:本荟萃分析调查了睾酮替代疗法[TRT]与颈动脉粥样硬化之间的关系。方法:根据 PRISMA 指南,检索了 3 个数据库中截至 2023 年 6 月的研究。合格标准包括涉及接受外源性睾酮治疗的性腺功能减退男性的 RCT 和观察性研究,其中对 CIMT 进行了评估。CAA是主要结果,次要结果包括高密度脂蛋白、低密度脂蛋白、CRP、总胆固醇和总睾酮。统计分析使用 Review Manager 进行。结果统计分析显示,TRT 与评估结果之间没有关联。总睾酮水平有明显增加,这说明 TRT 有间接抗动脉粥样硬化的作用。结论Meta分析表明,TRT与CIMT或其他指标之间没有关系,因此性腺功能低下的男性可以安全使用TRT。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Future Science OA
Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.00
自引率
4.00%
发文量
48
审稿时长
13 weeks
期刊介绍: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信